Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 2014

View Archived Issues

FDA grants orphan drug status to Re-188-P2045 for pancreatic cancer

TiGenix to develop allogeneic stem cell therapy for early RA and sepsis

Aclaris Therapeutics reports data from phase II trial of A-101 in seborrheic keratosis

FDA grants orphan drug status to two pulmonary disease treatments

VIB and Spain's CNIO partner for drug discovery

FDA grants small business waver of PDUFA fee for Rockwell's Triferic

Xenetic Biosciences reports safety data from ongoing phase II study of ErepoXen

Italian researchers patent novel LSD1 inhibitors

Novel SYK inhibitors prepared by Hutchison MediPharma

Roche designs new immunoproteasome inhibitors

Roche prepares new CB2 receptor agonists

Boehringer Ingelheim discloses novel GPR40 agonists

University of Bath designs novel products for cancer

Phase II study of DARPin abicipar pegol supports progressing to phase III

Phase I data reported for REGN-1400 in patients with cancer

Hanmi Pharmaceuticals and Kinex Pharmaceuticals report data from phase I/II trial of Oraxol

Clinical trial of cancer vaccine ETBX-011 completed

Vertex submits sNDA for Kalydeco in adults with CF and the R117H mutation

IND application submitted for ProHema in inherited metabolic disorders

Imaging neuroinflammation with a novel PET tracer

Amicus provides update on second phase III study of migalastat for Fabry disease

ISIS-GCGRRx improves glycemic control in type 2 diabetes trial

Ipsen submits applications in the U.S. and E.U. for Somatuline

BioAlliance Pharma and Topotarget approve merger to create Onxeo

Actavis completes acquisition of Forest Laboratories, Furiex in favor of its acquisition

FDA awards breakthrough therapy designation to blinatumomab in ALL

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...